Neratinib in the Early-Stage/Extended Adjuvant Breast Cancer Patient: Q&A

被引：0
作者：
O'Shaughnessy, Joyce A.
O'Regan, Ruth
Isaacs, Claudine
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
[21]   Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer [J].
Lumachi, Franco ;
Santeufemia, Davide A. ;
Fadda, Giovanni M. ;
Tozzoli, Renato ;
Chiara, Giordano B. ;
Basso, Stefano M. M. .
MEDICINAL CHEMISTRY, 2016, 12 (03) :261-267
[22]   Use of SERMs for the adjuvant therapy of early-stage breast cancer [J].
Wolff, AC ;
Davidson, NE .
SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 :80-88
[23]   Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer [J].
Fujii, Takeo ;
Le Du, Fanny ;
Xiao, Lianchun ;
Kogawa, Takahiro ;
Barcenas, Carlos H. ;
Alvarez, Ricardo H. ;
Valero, Vicente ;
Shen, Yu ;
Ueno, Naoto T. .
JAMA ONCOLOGY, 2015, 1 (09) :1311-1318
[24]   Early-Stage Breast Cancer - Strategies for Adjuvant Systemic Therapy [J].
Goerner, M. ;
Justz, M. ;
Gerull, S. .
HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE, 2008, 40 (04) :230-238
[25]   Role of adjuvant endocrine therapy in early-stage breast cancer [J].
Muss, HB .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :313-321
[26]   Progress in systemic adjuvant therapy of early-stage breast cancer [J].
William J. Gradishar ;
Ruth M. O'Regan .
International Journal of Clinical Oncology, 2003, 8 (4) :239-247
[27]   Adjuvant tamoxifen adherence in men with early-stage breast cancer [J].
Oke, Oluchi ;
Niu, Jiangong ;
Chavez-MacGregor, Mariana ;
Zhao, Hui ;
Giordano, Sharon H. .
CANCER, 2022, 128 (01) :59-64
[28]   Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer [J].
Tran, Phuong T. ;
Diaby, Vakaramoko .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (02) :221-221
[29]   Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer [J].
Schwartz, Naomi R. M. ;
Flanagan, Meghan R. ;
Babigumira, Joseph B. ;
Steuten, Lotte M. ;
Roth, Joshua A. .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (10) :1133-1139
[30]   Association between treatment duration and overall survival in early-stage HER2+breast cancer patients receiving extended adjuvant therapy with neratinib in the ExteNET trial [J].
Overkamp, Friedrich ;
Moy, Beverly ;
Coudert, Bruno ;
Wong, Alvin ;
Chan, Arlene .
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) :31-31
12345